The Institute for Children's Diseases currently possesses all the most important drugs that can affect the final prognosis of the disease. If we had a shortcoming, it will be bridged by intervention procurement, said in Boje jutra, the director of the Institute, Velibor Majić.
Majić says that during this time of the year, the Clinical Center of Montenegro plans to purchase medicines and materials in relation to the stock, but that this number can vary, which was greatly affected by the covid pandemic.
"There was no lack of more important drugs that can affect the prognosis of the disease, and if we had a shortage, it was bridged by interventional procurement. We have very expensive drugs, which cost 50.000 euros per dose. Three children are currently receiving this kind of therapy," Majić said.
According to the latest data, 85 children are being treated at the Institute.
Majić points out that since 2000, the children's hospital has started applying the system of integrated health care.
"Until 3-4 years ago, we didn't have our own orthopedist, now we have two. We have our own ophthalmologists, otolaryngologists. The situation has improved in this regard, both in terms of personnel and health care."
Majić states that there are also "bottlenecks".
"There is a lack of radiologists, but with the increased efforts of colleagues, this is not noticed. We have one pediatric physiatrist. We have a potential problem in neonatology, which we have overcome at the moment, we have received three female colleagues. Due to the number of practitioners and the age structure of the staff, it was potentially one of the bigger problems in to the state," Majić said.
It says that the frame cannot be created overnight.
When it comes to the department for newborns, its capacity is 28 children, and Majić states that a few days ago there were 43.
"It is very demanding in that space to make sure that you don't get an intrahospital infection, and that all the children are cared for in a good way," he concluded.
Bonus video:
